Let me know when the data is updated again

RAGAR SA DE CV

Summary of sales of medicines and medical supplies

1,613 purchase as supplier for a total of 4.1 mil millones (4,080,300,706.201 ) between 2008 and 2018.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

9.8 millones pesos mexicanos (9,759,032.131 MXN)

Overcost in %

4.76 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
FUROSEMIDA 95 202 millones MXN 52,110.9 MXN 1.63 % 2009 - 2018
COMPLEJO B 88 666.5 millones MXN 101,749.6 MXN 0.526 % 2013 - 2018
CALCIO 77 18.1 millones MXN 55,363.7 MXN 0.252 % 2009 - 2013
DIFENHIDRAMINA 74 26.3 millones MXN 141,063.5 MXN 4.12 % 2009 - 2016
ESPIRONOLACTONA 65 140.9 millones MXN 144,586.2 MXN 2.97 % 2012 - 2018
ÁCIDO RETINOICO 59 6.7 millones MXN 865.6 MXN 0.892 % 2012 - 2018
BEZAFIBRATO 48 541.1 millones MXN 3.3 millones MXN 2.53 % 2009 - 2016
CIPROFLOXACINO 48 245.7 millones MXN 288,375 MXN 6.65 % 2013 - 2018
AMBROXOL 47 78.5 millones MXN 1.1 millones MXN 7.48 % 2009 - 2018
PROPAFENONA 45 36.2 millones MXN 43,068.3 MXN 0.617 % 2010 - 2016

Location

Country

México

GENERAL INFORMATION

Alternative names

  • RAGAR, S.A. DE C.V.
  • RAGAR S.A. DE C.V.
  • RAGAR S.A. D C.V.
  • RAGAR S A DE C V
  • RAGAR S.A. DE C.V
  • RAGAR, S. A DE C. V.

Entity type

profit

Identifiers

RUPC: 631

RFC: RAG960828EF8

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER